For the year ending 2025-12-31, TPST has $16,931K in assets. $10,263K in debts. $7,707K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 7,707 | |||
| Prepaid expenses and other current assets | 562 | |||
| Total current assets | 8,269 | |||
| Property and equipment | 2,058 | |||
| Less accumulated depreciation | 1,453 | |||
| Property and equipmentnet | 605 | |||
| Operating lease right-of-use assets | 7,540 | |||
| Other noncurrent assets | 517 | |||
| Total assets | 16,931 | |||
| Accounts payable | 1,038 | |||
| Accrued expenses | 937 | |||
| Current loan payable (net of discount and issuance costs of nil and 74, respectively) | 0 | |||
| Current operating lease liabilities | 1,192 | |||
| Accrued compensation | 147 | |||
| Interest payable | 0 | |||
| Total current liabilities | 3,314 | |||
| Operating lease liabilities, less current portion | 6,949 | |||
| Total liabilities | 10,263 | |||
| Common stock, 0.001 par value 100,000,000 shares authorized 4,927,161 and 3,382,432 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 5 | |||
| Additional paid-in capital | 240,031 | |||
| Accumulated deficit | -233,368 | |||
| Total stockholders' equity | 6,668 | |||
| Total liabilities and stockholders' equity | 16,931 | |||
Tempest Therapeutics, Inc. (TPST)
Tempest Therapeutics, Inc. (TPST)